scholarly article | Q13442814 |
P2093 | author name string | A Schürmann | |
G Schlüter | |||
G Schmuck | |||
P2860 | cites work | Electrical activities in thin sections from the mammalian brain maintained in chemically-defined media in vitro. | Q51225549 |
Glycine-induced CA1 excitotoxicity in the rat hippocampal slice. | Q51619931 | ||
In vitro and in vivo characterization of the NMDA receptor-linked strychnine-insensitive glycine site | Q67521485 | ||
Glycine reverses 7-Cl kynurenate blockade of glutamate neurotoxicity in cell culture | Q69353820 | ||
Attenuated inhibition by levofloxacin, l-isomer of ofloxacin, on GABA response in the dissociated rat hippocampal neurons | Q71525856 | ||
Central nervous system toxicity of quinolones: human and animal findings | Q28329722 | ||
The proconvulsive activity of quinolone antibiotics in an animal model | Q28333203 | ||
Magnesium gates glutamate-activated channels in mouse central neurones | Q29616237 | ||
Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites | Q35354313 | ||
Gating of GABAergic Inhibition in Hippocampal Pyramidal Cells | Q36515579 | ||
Impact of chemical structure on quinolone potency, spectrum and side effects | Q36942967 | ||
Competitive antagonism of glycine at the N-methyl-d-aspartate (NMDA) receptor | Q37076226 | ||
Drug interactions with quinolones. | Q38364042 | ||
In vitro modulation of hippocampal pyramidal cell response by quinolones: effects of HA 966 and gamma-hydroxybutyric acid. | Q39783134 | ||
Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes | Q39817630 | ||
Hippocampal activity in the presence of quinolones and fenbufen in vitro | Q40284282 | ||
Antagonism of GABAA receptors by 4-quinolones | Q40855311 | ||
The effects of quinolones and NSAIDs upon GABA-evoked currents recorded from rat dorsal root ganglion neurones | Q41129678 | ||
Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS. | Q42199003 | ||
Effects of some quinolones on imipenem-induced seizures in DBA/2 mice | Q42283463 | ||
Quinolones do not interact with NMDA receptor in dissociated rat hippocampal neurons. | Q48637807 | ||
Interaction of various non-steroidal anti-inflammatories and quinolone antimicrobials on GABA response in rat dissociated hippocampal pyramidal neurons | Q48638164 | ||
Quinolones and fenbufen interact with GABAA receptor in dissociated hippocampal cells of rat | Q48683939 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1831-1836 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model | |
P478 | volume | 42 |
Q42922049 | A seizure attributed to ofloxacine in a woman undergoing detoxification for alcohol dependence |
Q36862757 | Association between oral fluoroquinolones and seizures: A self-controlled case series study |
Q44019765 | Clinical toxicological aspects of fluoroquinolones |
Q37003271 | Clonic Seizures in GAERS Rats after Oral Administration of Enrofloxacin |
Q28146268 | Comparative tolerability of the newer fluoroquinolone antibacterials |
Q43294249 | Convulsant activity and pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of gemifloxacin in rats |
Q28066841 | Dysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review) |
Q44525399 | Evaluation of the possible epileptogenic activity of ciprofloxacin: the role of Nigella sativa on amino acids neurotransmitters |
Q34958317 | Fluoroquinolones for the treatment of outpatient community-acquired pneumonia |
Q35086805 | Fluoroquinolones in the elderly: safety considerations |
Q36047066 | Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy |
Q33588540 | Moxifloxacin |
Q35846371 | Moxifloxacin Induced Seizures -A Case Report |
Q28373212 | Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections |
Q39471040 | Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats |
Q48121689 | Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability |
Q33717059 | Potential interactions of the extended-spectrum fluoroquinolones with the CNS. |
Q40782394 | Quinolone antibiotics and suicidal behavior: analysis of the World Health Organization's adverse drug reactions database and discussion of potential mechanisms |
Q35074608 | Quinolones in dermatology |
Q46971476 | Retinal safety of a new fluoroquinolone, pradofloxacin, in cats: assessment with electroretinography |
Q34617485 | Safety considerations of fluoroquinolones in the elderly: an update |
Q34110521 | Safety profile of the fluoroquinolones: focus on levofloxacin |
Q28243911 | Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes |
Q37586997 | Seizures associated with levofloxacin: case presentation and literature review |
Q42951097 | The Effect of Ciprofloxacin Injection on Genetically Absence Prone (Wag/Rij) Rat's Electroencephalogram Characteristics. |
Q30311089 | The efficacy of trovafloxacin versus ceftriaxone in the treatment of experimental brain abscess/cerebritis in the rat. |
Q33770084 | Toxicity of quinolones |
Search more.